1-anilino-8-naphthalenesulfonate and End Stage Liver Disease

1-anilino-8-naphthalenesulfonate has been researched along with End Stage Liver Disease in 5 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Kelava, T	1
Turcic, P	1
Markotic, A	1
Ostojic, A	1
Sisl, D	1
Mrzljak, A	1
Kalambokis, GN	1
Tsianos, EV	1
Serfaty, L	1
Castera, L	1
Marcellin, P	1
do O, NT	1
Eurich, D	1
Trautwein, C	1
Neuhaus, P	1
Neumann, UP	1
Wasmuth, HE	1
Valenti, L	1
Fargion, S	1

Reviews

1 review available for 1-anilino-8-naphthalenesulfonate and End Stage Liver Disease

Article	Year
Importance of genetic polymorphisms in liver transplantation outcomes. World journal of gastroenterology, 2020, Mar-28, Volume: 26, Issue:12 Topics: Cytochrome P-450 CYP3A; End Stage Liver Disease; Female; Graft Rejection; Humans; Immunosuppressive	2020

Other Studies

4 other studies available for 1-anilino-8-naphthalenesulfonate and End Stage Liver Disease

Article	Year
Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites who are using beta-blockers. Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:4 Topics: End Stage Liver Disease; Female; Genetic Markers; Hepatitis C, Chronic; Humans; Lipase; Liver Transp	2011
First European Young Hepatologist Workshop: topics and advances. Clinics and research in hepatology and gastroenterology, 2011, Volume: 35 Suppl 1 Topics: Carcinoma, Hepatocellular; End Stage Liver Disease; European Union; Fatty Liver; Genetic Markers; Hu	2011
The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C. Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:4 Topics: Cohort Studies; Disease Progression; End Stage Liver Disease; Female; Genetic Markers; Graft Rejecti	2011
Patatin-like phospholipase domain containing-3 Ile148Met and fibrosis progression after liver transplantation. Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:4 Topics: End Stage Liver Disease; Female; Genetic Markers; Hepatitis C, Chronic; Humans; Lipase; Liver Transp	2011